Actively Recruiting
A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors
Led by Shanghai Hengrui Pharmaceutical Co., Ltd. · Updated on 2024-10-18
201
Participants Needed
1
Research Sites
112 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is being conducted to evaluate safety, tolerability, pharmacokinetics and preliminary efficacy of SHR-7787 injection monotherapy for patients with advanced solid tumors. To explore the reasonable dosage of SHR-7787 injection monotherapy for patients with advanced solid tumors.
CONDITIONS
Official Title
A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to understand and voluntarily agree to participate by giving written informed consent
- Diagnosis of unresectable recurrent or metastatic solid tumors
- Presence of at least one measurable tumor lesion
- Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1
- Adequate organ functions as defined in the protocol
- Life expectancy of 3 months or more
You will not qualify if you...
- Known active central nervous system (CNS) metastases
- History of another malignancy within five years before the first dose
- Tumor-related pain that cannot be controlled
- Serious cardiovascular or cerebrovascular diseases
- Uncontrollable third-space effusion such as pleural, pericardial, or peritoneal effusion
- Severe infections
- History of immunodeficiency
- History of autoimmune diseases
- Unresolved toxicity greater than Grade 1 from prior anti-tumor therapy
- Active infection
- Pregnant or nursing women
- Known serious allergic reactions to the investigational product or its main ingredients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China, 200433
Actively Recruiting
Research Team
K
Ke Ma
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here